Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 16506-27-7
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of bendamustine during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy, especially alkylating agents such as bendamustine.[1] Based on the half-life of the drug and its metabolites, the drug should be eliminated from the milk by 24 to 48 hours after the last dose. The manufacturer recommends that breastfeeding be discontinued during bendamustine therapy and for at least 1 week after the last dose.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Some evidence indicates that the closely related drug carmustine can increase serum prolactin.[2]
References
- 1.
- Pistilli B, Bellettini G, Giovannetti E, et al. Chemotherapy, targeted agents, antiemetics and growth-factors in human milk: How should we counsel cancer patients about breastfeeding? Cancer Treat Rev. 2013;39:207–11. [PubMed: 23199900]
- 2.
- Constine LS, Rubin P, Woolf PD, et al. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies. J Clin Oncol. 1987;5:1841–51. [PubMed: 3681371]
Substance Identification
Substance Name
Bendamustine
CAS Registry Number
16506-27-7
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Carmustine.[Drugs and Lactation Database (...]Review Carmustine.. Drugs and Lactation Database (LactMed®). 2006
- Review Venetoclax.[Drugs and Lactation Database (...]Review Venetoclax.. Drugs and Lactation Database (LactMed®). 2006
- Review Melatonin.[Drugs and Lactation Database (...]Review Melatonin.. Drugs and Lactation Database (LactMed®). 2006
- Breastfeeding for procedural pain in infants beyond the neonatal period.[Cochrane Database Syst Rev. 2016]Breastfeeding for procedural pain in infants beyond the neonatal period.Harrison D, Reszel J, Bueno M, Sampson M, Shah VS, Taddio A, Larocque C, Turner L. Cochrane Database Syst Rev. 2016 Oct 28; 10(10):CD011248. Epub 2016 Oct 28.
- Aspirin (single dose) for perineal pain in the early postpartum period.[Cochrane Database Syst Rev. 2017]Aspirin (single dose) for perineal pain in the early postpartum period.Molakatalla S, Shepherd E, Grivell RM. Cochrane Database Syst Rev. 2017 Feb 9; 2(2):CD012129. Epub 2017 Feb 9.
- Bendamustine - Drugs and Lactation Database (LactMed®)Bendamustine - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...